First Financial Bancorp. FFBC

Earlier this month, First Financial Bancorp.’s board appointed long-time executive James M. Anderson as President while retaining his Chief Financial Officer role, alongside promoting Amanda N. Neeley to Chief Banking Officer and Malcolm A. Myers to Chief Operating Officer, effective September 14, 2026. These leadership changes consolidate financial oversight and elevate experienced internal talent across banking, operations, and credit support functions, potentially sharpening execution on...

First Financial Bancorp (FFBC) has been in focus after its shares climbed 3.4% following an upgrade from Truist Securities, only weeks after a broad reshuffle of the company’s senior leadership team. Recent trading shows that momentum in First Financial Bancorp has cooled slightly after a strong year. The 30 day share price return is down 1.28% and the 90 day move is down 4.42%, even as the year to date share price return sits at 29.14% and the 1 year total shareholder return is 29.98%. This...

Shares of regional banking company First Financial Bancorp (NASDAQ:FFBC) jumped 3.4% in the afternoon session after Truist Securities analyst Brian Foran upgraded the stock to Buy from Hold and raised his price target to $37 from $35, as reported by Streetinsider. Foran wrote that he sees mid- to high-single-digit upside to consensus as rising rates filter into results, and that the shares were down more than 10% from their July peak. First Financial is asset-sensitive, so a higher-rate tape fee

First Financial Bancorp. (Nasdaq: FFBC) is announcing several important leadership promotions and expanded executive responsibilities within the Company. The organizational changes, which are effective immediately, are designed to create opportunities for rising top talent, place future leaders into positions to learn and grow while senior leaders are in place, and support thoughtful succession planning across the organization.

Looking back on regional banks stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including First Financial Bancorp (NASDAQ:FFBC) and its peers.

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some may still have unproven business models, leaving them vulnerable to the ebbs and flows of the broader market.

First Financial Bancorp has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 16.6% to $32.68 per share while the index has gained 12%.

KeyCorp (NYSE:KEY) announced that Chris Doll has joined Key as Chief Strategy Officer & Deputy CFO, effective Aug. 31, 2026.

Growth is oxygen. But when it evaporates, the consequences can be severe - ask anyone who bought Cisco in the Dot-Com Bubble or newer investors who lived through the 2020 to 2022 COVID cycle.

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.

First Financial Bancorp (FFBC) has drawn fresh attention after reporting second quarter 2026 results, with net interest income of US$190.38 million and net income of US$76.46 million, alongside detailed six month figures. See our latest analysis for First Financial Bancorp. First Financial Bancorp shares fell 4.79% on the day of the Q2 2026 release, but still show a 6.32% 1 month share price return and a 35.35% year to date share price return, alongside a 44.86% 1 year total shareholder...

First Financial Bancorp (FFBC) reports an 8% increase in net income and strong loan growth, while navigating acquisition impacts and fee income challenges.

Arrowhead Pharmaceuticals (ARWR) said Wednesday topline results from its global phase 3 clinical stu

Moby summary of First Financial Bancorp.'s Q2 2026 earnings call